analyst-color

Ignite It
5 min read • June 1, 2017

Viridian Discusses The Spicer Effect On Marijuana Stocks: ‘It Wasn’t The Deathblow Some People Were Afraid Of’

Ignite It
2 min read • April 20, 2017

Cannabis Adoption Getting Higher; Analyst Sees It Killing Alcohol Stocks’ Buzz

Ignite It
4 min read • March 17, 2017

Garbage Companies & The Marijuana Industry: Expert Warns About Overvalued Cannabis Stocks

Ignite It
3 min read • February 24, 2017

Up In Smoke? DoJ Will ‘Take Action’ Against States That Have Legalized Marijuana

Ignite It
1 min read • February 23, 2017

Marijuana Industry Expert, Alan Brochstein, Responds to Spicer Comments on Marijuana: ‘There was absolutely no suggestion of any pending actions, but clearly there is a risk the federal gov’t walks away from the hands-off approach’

Ignite It
2 min read • February 10, 2017

Earth Science Tech: Another Marijuana Stock That Looks ‘Insanely Overvalued’

Ignite It
1 min read • February 7, 2017

Marijuana Industry Expert Alan Brochstein On GW Pharma’s Earnings Tells Benzinga :NDA filing for Epidiolex Seems To Have Been Pushed Back Slightly, Co. Now Saying “Mid 2017” Instead Of H1, “Mid” Could Mean A Bit Later Than June 30th

Ignite It
4 min read • January 5, 2017

5 Overvalued Cannabis Stocks – Part 1: New Investors Seem To Go For Flashy Names

Ignite It
2 min read • October 7, 2015

5 Charts On The Expanding Marijuana Industry

Ignite It
9 min read • May 29, 2015

Vice Index: Will The Boom In Prostitution, Gambling And Marijuana Last?

Ignite It
2 min read • March 26, 2015

6 Marijuana Bills In Congress Fail To Solve ‘Single Most Important’ Problem

Ignite It
1 min read • January 5, 2015

CORRECTION — Pot Stocks Pay Off: Here’s How The Marijuana Sector Fared Last Year

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.